^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

iCAR-ILC-N101

i
Other names: iCAR-ILC-N101, GPC3-CAR expressing iPS cell-derived innate lymphoid/natural killer cells
Associations
Trials
Company:
National Cancer Center Hospital East
Drug class:
GPC-3 inhibitor
Associations
Trials